Strategic Capital Group’s Pfizer PFE Stock Holding History

Strategic Capital Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$3.48M	Buy	123,516 +2,032	+2%	+$57.9K	1.09%	32
2014 Q1	$3.7M	Buy	121,484 +43,529	+56%	+$1.3M	1.2%	23
2013 Q4	$2.27M	Sell	77,955 -35,900	-32%	-$1.04M	1.76%	12
2013 Q3	$3.1M	Buy	113,855 +18,028	+19%	+$491K	1.17%	22
2013 Q2	$2.55M	Buy	+95,827	New	+$2.65M	1.27%	17

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Strategic Capital Group's PFE Position: Q2 2014 in Review

Strategic Capital Group increased its Pfizer (PFE) stake by 1.7% in Q2 2014, buying an estimated $57.9K and bringing the position to 123,516 shares worth $3.48M. The position accounts for 1.09% of the portfolio, ranked #32.

Strategic Capital Group first reported a position in PFE in Q2 2013 and has held it in 5 quarters since. The position peaked at $3.7M in Q1 2014. 1,745 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

Strategic Capital Group held 123,516 shares of Pfizer worth $3.48M as of Q2 2014.
Strategic Capital Group bought 2,032 Pfizer shares in Q2 2014, an estimated $57.9K.
Pfizer made up 1.09% of Strategic Capital Group's portfolio in Q2 2014, its #32 holding.
Strategic Capital Group first reported a position in Pfizer in Q2 2013 and has held it in 5 quarters since.
Strategic Capital Group's Pfizer position peaked at $3.7M in Q1 2014.
1,745 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Strategic Capital Group's 13F filing for Q2 2014, filed 14 Jul 2014.